The value of information and the ethics of personal-genomic screening.
dc.contributor.author | Schwartz, Peter H. | |
dc.date.accessioned | 2009-10-14T19:29:08Z | |
dc.date.available | 2009-10-14T19:29:08Z | |
dc.date.issued | 2009-04 | |
dc.description.abstract | Personal genomic screening, especially when marketed direct-to-consumers, threatens to worsen the inefficient use of healthcare resources that Burger and Kass discuss in the case of unproven screening tests. The information that genomic and other screening tests can provide may well have value for many patients, but its effective use in healthcare depends on careful thought about the ethics of testing and the proper regulation of unproven interventions. | en |
dc.identifier.citation | Schwartz PH. The value of information and the ethics of personal-genomic screening. Am J Bioeth. 2009 Apr;9(4):26-7. | en |
dc.identifier.other | 10.1080/15265160802716878 | |
dc.identifier.uri | https://hdl.handle.net/1805/1962 | |
dc.language.iso | en_US | en |
dc.publisher | The American Journal of Bioethics: AJOB | en |
dc.subject | Economics | en |
dc.subject | Ethics | en |
dc.subject | Evidence-Based Medicine | en |
dc.subject | Genetic Screening | en |
dc.subject | Genome, Human | en |
dc.subject | Health Services Accessibility | en |
dc.subject | Mass Screening | en |
dc.subject | Practice Guidelines as Topic | en |
dc.title | The value of information and the ethics of personal-genomic screening. | en |
dc.type | Article | en |